Dr. Jonathan MilnerAstellas Venture ManagementAmadeus CapitalBgfParkwalk Advisors
Description
PhoreMost has successfully added around £9 million to its Series B financing, increasing the total to around £38 million. This funding will enable the advancement of its pipeline in oncology and inflammatory diseases through preclinical development.
Who to call at PhoreMost, and when
A new round usually means PhoreMost is about to hire and buy. The teams that reach out first get the meeting.
An alert the day PhoreMost raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at PhoreMost, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
PhoreMost
Location
Cambridge, England, United Kingdom
About
PhoreMost is a biopharmaceutical company specializing in the development of next-generation drug targets through its innovative SITESEEKER platform. The company focuses on degrader programs, particularly in oncology and inflammatory diseases. With recent funding, it aims to advance its pipeline of novel degrader assets toward preclinical development. PhoreMost is committed to revolutionizing medicine through targeted protein degradation.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PhoreMost raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyTherapeuticsPharmaceuticalBiopharma